Myristoylation cannot functionally replace the isoprenylation of Rab5.

Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Myristoylation cannot functionally replace the isoprenylation of Rab5.

Arch Biochem Biophys. 1995 Jan 10;316(1):529-34. Unique Identifier : AIDSLINE MED/95142675
Li G; Barbieri MA; Stahl PD; Department of Cell Biology & Physiology, Washington University; School of Medicine, St. Louis, Missouri 63110.

Abstract: C-terminal isoprenylation is necessary for the small GTPase Rab5 to associate with early endosomes and to exert its regulatory function in endocytosis. In this study, we tested whether Rab5 could retain its membrane association and biological function if the isoprenylation were replaced by another type of lipid modification (myristoylation). Rab5 mutants were constructed that contained both isoprenylation and myristoylation (Gag-Rab5), myristoylation only (Gag-Rab5 delta C4), and neither of the modifications (Rab5 delta C4), respectively. These mutants and wild-type Rab5 were expressed, via a Sindbis virus vector, in cultured BHK-21 cells and their membrane association and biological activity (stimulation of endocytosis) were examined. Wild-type Rab5 was isoprenylated, membrane associated, and biologically active. With additional myristoylation, Gag-Rab5 showed increased affinity for membranes but decreased biological activity. Rab5 delta C4 contained no lipid modifications, failed to associate with membranes, and had no biological activity. With myristoylation (Gag-Rab5 delta C4), there was a significant increase in membrane association (approximately 30%). However, this increased membrane association did not result in any recovery of Rab5 activity. In light of these data, we conclude that N-terminal myristoylation cannot functionally replace the C-terminal isoprenylation of Rab5. Furthermore, myristoylation of Rab5 (Gag-Rab5) interferes with its normal function.

Keywords: Animal Base Sequence Biological Markers Biological Transport Cells, Cultured Diterpenes/METABOLISM Endocytosis/*PHYSIOLOGY G-Proteins/GENETICS/*PHYSIOLOGY Gene Products, gag/GENETICS Hamsters Horseradish Peroxidase/METABOLISM Membranes/METABOLISM Molecular Sequence Data Mutation Myristic Acids/*METABOLISM Protein Isoprenylation *Protein Processing, Post-Translational Recombinant Fusion Proteins/PHYSIOLOGY Subcellular Fractions Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. JOURNAL ARTICLE $KWDproteinprocessing,post-translationalrecombinantfusionproteins/physiologysubcellularfractionssupport,non-u$
950530
M9550787

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .